Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Vermeulen

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Cell Reports|October 13, 2015
ER-Stress-Induced Differentiation Sensitizes Colon Cancer Stem Cells to ChemotherapyMattheus C B Wielenga, Selcuk Colak, Jarom Heijmans, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 26, 2023
Caffeine Limits Expansion of Apc-Deficient Clones in the Intestine by NOTUM InhibitionMilou S van Driel, Jasmijn D G Linssen, Dustin J Flanagan, et al.
Cancers|March 6, 2021
AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal TransitionJoyce Y Buikhuisen, Patricia M Gomez Barila, Arezo Torang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular MarkersGabrielle Jongeneel, Marjolein J E Greuter, Natalia Kunst, et al.
Elife|August 23, 2021
Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumoniaAlex R Schuurman, Tom DY Reijnders, Anno Saris, et al.
Medical Oncology (Northwood, London, England)|July 31, 2021
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitroRichard C Zieren, Liang Dong, David J Clark, et al.
Acta Oncologica (Stockholm, Sweden)|April 28, 2026
Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancerPascale J M Schafrat, Tim R De Back, Felice N Van Erning, et al.
British Journal of Cancer|July 13, 2021
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backboneSanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott, et al.
Molecular Oncology|March 17, 2022
Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypesRonja S Adam, Dennis Poel, Leandro Ferreira Moreno, et al.
Cancer Epidemiology|October 17, 2025
Malignancies of the small intestine: incidence and trends in a nationwide registryPascale J M Schafrat, Felice N van Erning, Koos Zwinderman, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Cell Reports|October 13, 2015
ER-Stress-Induced Differentiation Sensitizes Colon Cancer Stem Cells to ChemotherapyMattheus C B Wielenga, Selcuk Colak, Jarom Heijmans, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 26, 2023
Caffeine Limits Expansion of Apc-Deficient Clones in the Intestine by NOTUM InhibitionMilou S van Driel, Jasmijn D G Linssen, Dustin J Flanagan, et al.
Cancers|March 6, 2021
AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal TransitionJoyce Y Buikhuisen, Patricia M Gomez Barila, Arezo Torang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular MarkersGabrielle Jongeneel, Marjolein J E Greuter, Natalia Kunst, et al.
Elife|August 23, 2021
Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumoniaAlex R Schuurman, Tom DY Reijnders, Anno Saris, et al.
Medical Oncology (Northwood, London, England)|July 31, 2021
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitroRichard C Zieren, Liang Dong, David J Clark, et al.
Acta Oncologica (Stockholm, Sweden)|April 28, 2026
Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancerPascale J M Schafrat, Tim R De Back, Felice N Van Erning, et al.
British Journal of Cancer|July 13, 2021
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backboneSanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott, et al.
Molecular Oncology|March 17, 2022
Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypesRonja S Adam, Dennis Poel, Leandro Ferreira Moreno, et al.
Cancer Epidemiology|October 17, 2025
Malignancies of the small intestine: incidence and trends in a nationwide registryPascale J M Schafrat, Felice N van Erning, Koos Zwinderman, et al.
Pageof 16